Primary Intensivists and Primary Nurses to Decrease Pediatric ICU Length of Stay (PIPRNs)

July 24, 2020 updated by: Jeffrey D. Edwards, Columbia University
This is a randomized control trial of PICU patients admitted for 7 days and expected to remain for at least another 3 days and who have a complex chronic condition. Patients will be randomized to usual care or usual care plus a primary intensivist and group of primary nurses (to facilitate passing of important patient information and informed, expedited decision-making). The primary research question is whether having a primary intensivist and nurses decreases PICU length of stay.

Study Overview

Status

Completed

Conditions

Detailed Description

Long-stay intensive care unit (ICU) patients, or children who require prolonged hospitalization in the pediatric ICU (PICU), represent a minority of PICU patients but have a disproportionate impact on hospital resources and unfavorable outcomes, including morbidity, mortality, and repeated critical illness. These patients and their families have multifaceted needs (eg, tailored communication) that pose unique challenges to PICU providers and the parent-provider relationship. These experiences and needs are compounded and complicated by the transitory care that is typically provided by PICU. This transitory care may contribute to 1) patient/family dissatisfaction; 2) ineffective passing of important information day to day and week to week; and 3) delayed decision-making. These latter two potential consequences may, in turn, contribute to prolonged length of stay (LOS).

For these reasons, the investigators propose a randomized control trial to test whether primary intensivists and primary nurses can decrease PICU LOS for long-stay patients. A primary intensivist is one that remains a consistent physician-presence for the patient/family and PICU team throughout the child's PICU stay, despite changes in the intensivist(s) who orchestrates day-to-day management. Primary nurses are a team of PICU nurses who provide the all/most of the bedside care to the child. The investigators hypothesize that the long-stay PICU patients who are randomized to receive primary intensivists and nurses will have a statistically lower LOS than those patients who do not.

Study Type

Interventional

Enrollment (Actual)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 10032
        • Columbia University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • PICU patients of any age who

    • have a complex chronic condition
    • have been admitted to the PICU for one week and are predicted by the PICU attending to continue to be admitted for at least another 3 days.

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: HEALTH_SERVICES_RESEARCH
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Primary intensivist and nurses
Patients randomized to the experimental arm will have a primary intensivist and a team of primary nurses assigned to them.

Primary intensivist will have no active role in the daily management of patients. The primary intensivist should facilitate decision-making, be a liaison between the patient/family and PICU team, and be a resource of information for all. Responsibilities of primary intensivist:

  • Weekly check-in with and availability to patient/family
  • Attendance at family meetings
  • Availability to PICU team

Primary nurses will be a team of up to 7 ICU nurses who will provide as much of the bedside care as possible. Responsibilities of primary nurses:

  • Maintain a primary nurse binder (paper format) for on-going communication about the patient among the team members; it will be their discretion what is information is communicated.
  • The Primary Nurse or delegate will be involved in all team/family meetings and will be expected/given an opportunity to speak during these meetings.
NO_INTERVENTION: Control
Patients who are randomized to the control group will receive usual care and not be assigned a primary intensivist or nurses.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PICU length of stay
Time Frame: Up to 2 years
Total number of days in which an individual stays in the PICU
Up to 2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Family satisfaction
Time Frame: Up to 2 years
In order to assess family satisfaction, families of all PICU patients (with PICU lengths of stay > 10 days) will be asked to complete a short anonymous questionnaire (Likert Scale) at the time of ICU discharge or within a few days when the patient is still hospitalized, if discharged late at night or over a weekend.
Up to 2 years
Provider satisfaction
Time Frame: Up to 2 years
In order assess provider satisfaction, all PICU attendings, fellows, and nurses will be verbally consented and asked to complete a short anonymous questionnaire (Likert Scale) at one of two time points-1) at the end of the study or 2) before the staff member leaves
Up to 2 years
Percentage of family meetings attended by a primary nurse
Time Frame: Up to 2 years
Number of meetings a nurse participated in divided by the number of meetings
Up to 2 years
Duration of invasive mechanical ventilation in those patients without chronic respiratory failure and who are on invasive mechanical ventilation from the time of enrollment
Time Frame: Up to 2 years
Measured in days.
Up to 2 years
Time to tracheotomy in those who undergo a tracheotomy
Time Frame: Up to 2 years
Measured in days.
Up to 2 years
Incidence of nursing-related KEEPSAFE reports recorded after enrollment
Time Frame: Up to 2 years
total number of reports that are recorded.
Up to 2 years
Timing of involvement of Patient Care Services
Time Frame: Up to 2 years
Measured in days.
Up to 2 years
Incidence of ICU-acquired infections after enrollment
Time Frame: Up to 2 years
Total number of ICU-acquired infections
Up to 2 years
Number of documented family meetings
Time Frame: Up to 2 years
Total number of family meetings.
Up to 2 years
Incidence of unplanned re-admissions to a PICU within 48 hours of PICU discharge
Time Frame: Up to 2 years
Total number of unplanned re-admissions to a PICU.
Up to 2 years
Percentage of primary intensivists who meet with families
Time Frame: Up to 2 years
Measured by total number of meeting divided by the number of weeks after enrollment.
Up to 2 years
Total number of shifts that are not being covered by a primary nurse,
Time Frame: Up to 2 years
The Bice-Boxerman Continuity of Care Index will be used to measure continuity compliance in terms of the total number of shifts not covered by a primary nurse.
Up to 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jeffrey Edwards, MD, Columbia University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 1, 2018

Primary Completion (ACTUAL)

February 3, 2020

Study Completion (ACTUAL)

February 3, 2020

Study Registration Dates

First Submitted

November 28, 2017

First Submitted That Met QC Criteria

December 1, 2017

First Posted (ACTUAL)

December 7, 2017

Study Record Updates

Last Update Posted (ACTUAL)

July 27, 2020

Last Update Submitted That Met QC Criteria

July 24, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • AAAR5445

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on ICU Length of Stay

Clinical Trials on Primary intensivist and nurses

Subscribe